Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.20.2
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2018 $ 5,541,960 $ 794 $ 204,891,358 $ (30,300) $ (199,319,892)
Beginning Balance, Shares at Dec. 31, 2018   7,940,931      
Share-based compensation 323,774   323,774    
Unrealized gain (loss) on marketable securities 31,336     31,336  
Net income (loss) 11,587,015       11,587,015
Ending balance at Mar. 31, 2019 17,484,085 $ 794 205,215,132 1,036 (187,732,877)
Ending balance, Shares at Mar. 31, 2019   7,940,931      
Beginning Balance at Dec. 31, 2018 5,541,960 $ 794 204,891,358 (30,300) (199,319,892)
Beginning Balance, Shares at Dec. 31, 2018   7,940,931      
Net income (loss) (2,439,009)        
Ending balance at Sep. 30, 2019 4,218,957 $ 794 205,977,064   (201,758,901)
Ending balance, Shares at Sep. 30, 2019   7,940,931      
Beginning Balance at Mar. 31, 2019 17,484,085 $ 794 205,215,132 1,036 (187,732,877)
Beginning Balance, Shares at Mar. 31, 2019   7,940,931      
Share-based compensation 369,927   369,927    
Unrealized gain (loss) on marketable securities 960     960  
Net income (loss) (8,666,906)       (8,666,906)
Ending balance at Jun. 30, 2019 9,188,066 $ 794 205,585,059 1,996 (196,399,783)
Ending balance, Shares at Jun. 30, 2019   7,940,931      
Share-based compensation 392,005   392,005    
Unrealized gain (loss) on marketable securities (1,996)     (1,996)  
Net income (loss) (5,359,118)       (5,359,118)
Ending balance at Sep. 30, 2019 4,218,957 $ 794 205,977,064   (201,758,901)
Ending balance, Shares at Sep. 30, 2019   7,940,931      
Beginning Balance at Dec. 31, 2019 15,544,906 $ 1,533 227,657,758   (212,114,385)
Beginning Balance, Shares at Dec. 31, 2019   15,332,042      
Share-based compensation 632,902   632,902    
Unrealized gain (loss) on marketable securities 9,199     9,199  
Net income (loss) (7,578,486)       (7,578,486)
Ending balance at Mar. 31, 2020 8,608,521 $ 1,533 228,290,660 9,199 (219,692,871)
Ending balance, Shares at Mar. 31, 2020   15,332,042      
Beginning Balance at Dec. 31, 2019 $ 15,544,906 $ 1,533 227,657,758   (212,114,385)
Beginning Balance, Shares at Dec. 31, 2019   15,332,042      
Issuance of common stock for exercise of options, Shares 750        
Net income (loss) $ (21,751,291)        
Ending balance at Sep. 30, 2020 18,397,103 $ 2,781 252,268,303 (8,305) (233,865,676)
Ending balance, Shares at Sep. 30, 2020   27,810,082      
Beginning Balance at Mar. 31, 2020 8,608,521 $ 1,533 228,290,660 9,199 (219,692,871)
Beginning Balance, Shares at Mar. 31, 2020   15,332,042      
Issuance of securities in registered offering 21,108,627 $ 1,180 21,107,447    
Issuance of securities in registered offering, Shares   11,797,752      
Issuance of securities in private placement 2,999,994 $ 67 2,999,927    
Issuance of securities in private placement, Shares   674,156      
Financing cost of sale of securities (1,462,310)   (1,462,310)    
Issuance of common stock for exercise of options, Shares   282      
Share-based compensation 652,266   652,266    
Unrealized gain (loss) on marketable securities (16,328)     (16,328)  
Net income (loss) (17,617,236)       (17,617,236)
Ending balance at Jun. 30, 2020 14,273,534 $ 2,780 251,587,990 (7,129) (237,310,107)
Ending balance, Shares at Jun. 30, 2020   27,804,232      
Issuance of common stock for exercise of warrants 28,665 $ 1 28,664    
Issuance of common stock for exercise of warrants, Shares   5,850      
Share-based compensation 651,649   651,649    
Unrealized gain (loss) on marketable securities (1,176)     (1,176)  
Net income (loss) 3,444,431       3,444,431
Ending balance at Sep. 30, 2020 $ 18,397,103 $ 2,781 $ 252,268,303 $ (8,305) $ (233,865,676)
Ending balance, Shares at Sep. 30, 2020   27,810,082